We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Filling the gap between clinical trials and real life in the treatment of severe HCV recurrence after liver transplantation.
- Authors
Burra, Patrizia; Zanetto, Alberto
- Abstract
The article talks about filling gaps between clinical trials and real life in the treatment of severe hepatitis C (HCV) recurrence after liver transplantation. Topics discussed include use of daclatasvir (DCV) plus registered sofosbuvir (SOF), with or without ribavirin (RBV) in transplant, identification of low platelets count and low albumin levels in patients, and positive effect of antiviral regimen in patients with several negative predictors of response.
- Subjects
LIVER transplantation; HEPATITIS C; SOFOSBUVIR; RIBAVIRIN; BLOOD platelets
- Publication
Transplant International, 2017, Vol 30, Issue 3, p239
- ISSN
0934-0874
- Publication type
Article
- DOI
10.1111/tri.12917